Abstract:Antimicrobial resistance (AMR) poses a critical global health threat, underscoring the urgent need for innovative antibiotic discovery strategies. While recent advances in peptide design have yielded numerous antimicrobial agents, optimizing these molecules experimentally remains challenging due to unpredictable and resource-intensive trial-and-error approaches. Here, we introduce APEX Generative Optimization (APEXGO), a generative artificial intelligence (AI) framework that integrates a transformer-based variational autoencoder with Bayesian optimization to design and optimize antimicrobial peptides. Unlike traditional supervised learning approaches that screen fixed databases of existing molecules, APEXGO generates entirely novel peptide sequences through arbitrary modifications of template peptides, representing a paradigm shift in peptide design and antibiotic discovery. Our framework introduces a new peptide variational autoencoder with design and diversity constraints to maintain similarity to specific templates while enabling sequence innovation. This work represents the first in vitro and in vivo experimental validation of generative Bayesian optimization in any setting. Using ten de-extinct peptides as templates, APEXGO generated optimized derivatives with enhanced antimicrobial properties. We synthesized 100 of these optimized peptides and conducted comprehensive in vitro characterizations, including assessments of antimicrobial activity, mechanism of action, secondary structure, and cytotoxicity. Notably, APEXGO achieved an outstanding 85% ground-truth experimental hit rate and a 72% success rate in enhancing antimicrobial activity against clinically relevant Gram-negative pathogens, outperforming previously reported methods for antibiotic discovery and optimization. In preclinical mouse models of Acinetobacter baumannii infection, several AI-optimized molecules-most notably derivatives of mammuthusin-3 and mylodonin-2-exhibited potent anti-infective activity comparable to or exceeding that of polymyxin B, a widely used last-resort antibiotic. These findings highlight the potential of APEXGO as a novel generative AI approach for peptide design and antibiotic optimization, offering a powerful tool to accelerate antibiotic discovery and address the escalating challenge of AMR.

Improving the efficiency of evolutionary de novo peptide design: strategies for probing configuration and parameter settings.

A New DNA Genetic Algorithm and Its Application in Parameter Estimation

Global-Context Aware Generative Protein Design

Parameter estimation for time-varying system based on improved genetic algorithm

Generative De Novo Protein Design with Global Context

An integrative approach to protein sequence design through multiobjective optimization

An Improved Genetic Algorithm for Statistical Potential Function Design and Protein Structure Prediction

Proximal Exploration for Model-guided Protein Sequence Design

Heuristic algorithms in Evolutionary Computations and modular organization of biological macromolecules: applications to directed evolution

PARCE: Protocol for Amino acid Refinement through Computational Evolution

Conformational Analysis of Peptides Using Monte Carlo Simulations Combined with the Genetic Algorithm

Reinforcement learning-driven exploration of peptide space: accelerating generation of drug-like peptides

Computational peptide discovery with a genetic programming approach

Integrating Genetic Algorithms and Language Models for Enhanced Enzyme Design

An Efficient Parallel Algorithm For Accelerating Computational Protein Design

A Computationally Efficient Evolutionary Algorithm for Real-Parameter Optimization

Computational Site Saturation Mutagenesis of Canonical and Non-Canonical Amino Acids to Probe Protein-Peptide Interactions

A multi-objective evolutionary algorithm for protein structure prediction with immune operators

COMPUTATIONAL ENZYME DESIGN APPROACHES WITH SIGNIFICANT BIOLOGICAL OUTCOMES: PROGRESS AND CHALLENGES

Beyond the Rotamer Library: Genetic Algorithm Combined with the Disturbing Mutation Process for Upbuilding Protein Side‐chains

A generative artificial intelligence approach for antibiotic optimization